Catalog No.S1762 Synonyms: Pyrazinoic Acid Amide
Molecular Weight(MW): 123.11
Pyrazinamide is an agent used to treat tuberculosis.
Purity & Quality Control
Choose Selective Antifection Inhibitors
|Description||Pyrazinamide is an agent used to treat tuberculosis.|
|In vitro||DMSO||25 mg/mL (203.07 mM)|
|Water||12 mg/mL (97.47 mM)|
|Ethanol||2 mg/mL (16.24 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Synonyms||Pyrazinoic Acid Amide|
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT00816426||Completed||Tuberculosis||National Institute of Allergy and Infectious Diseases (NIAID)|Korean Center for Disease Control and Prevention|International Tuberculosis Research Center|Novartis Institute for Tropical Medicine|Asian Medical Center|National Institutes of Health Clinical Center (CC)||December 29, 2008||Phase 1|
|NCT02975570||Not yet recruiting||Tuberculosis Multi Drug Resistant Active||Boston University|Westat|University of Florida||August 2017||Phase 3|
|NCT02754765||Recruiting||Tuberculosis, Multidrug-Resistant||Médecins Sans Frontières France|Partners in Health|Harvard Medical School|Epicentre|Institute of Tropical Medicine, Belgium|Ministry of Health, Kyrgyzstan|National Center for Tuberculosis Problems, Kazakhstan|Ministry of Health, Lesotho|National Center for Tuberculosis and Lung Diseases, Georgia|Socios En Salud, Peru||December 2016||Phase 3|
|NCT02901288||Recruiting||Tuberculosis, Pulmonary||Beijing Chest Hospital|Hubei Provincial Center for Disease Control and Prevention|Centre for Tuberculosis Control of Guangdong Province|Hunan Institute For Tuberculosis Control|Anhui Chest Hospital|Guangxi Center for Disease Prevention and Control|Wuhan Institute for Tuberculosis Control|Shanghai Pulmonary Hospital, Shanghai, China|China Shenyang Chest Hospital|Changchun Infectious Disease Hospital|The First Affiliated Hospital of Xinxiang Medical University|Public Health Clinical Center of Chengdu|Taiyuan Fourth Peoples Hospital|The Sixth Peoples Hospital of Nantong|The Tuberculosis Prevention and Treatment Hospital of Shanxi Province|Beijing Research Institute for Tuberculosis Control|The First Affiliated Hospital of Xiamen University|Infectious Disease Prevention Hospital in Heilongjiang Province|The Third Peoples Hospital of Zhenjiang|Tianjin centers for Disease Control and Prevention|Harbin Chest Hospital|Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC|Heilongjiang Province center for tuberculosis Control and Prevention|Tianjin Haihe Hospital|The Infectious Disease Hospital of Wangkai Zaozhuang|The Third Peoples Hospital of Kunming City|Kaifeng Pulmonary Disease Hospital|The Infectious Hospital of Hebi|Pulmonary Hospital of Lanzhou|The Fourth Peoples Hospital of Ningxia Autonomous Region|The 4th Peoples Hospital of Qinghai Province|The Fifth Peoples Hospital of Suzhou|Chongqing Infectious Disease Medical Center|Tuberculosis Hospital in Jilin Province|Sixth Peoples Hospital of Nanyang City|Wuhan medical treatment center||August 2016||Phase 4|
|NCT02409290||Recruiting||MDR-TB||IUATLD, Inc|Medical Research Council||April 2016||Phase 3|
|NCT02700347||Recruiting||Tuberculosis||National University Hospital, Singapore||February 2016||Phase 1|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.